TCG Crossover Management, LLC Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$333.4B
Holdings
21
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OPHTEURIVERIC BIO INC | 3,877,903 | $69.6B | 20.87% | |
| 2 | COGTCOGENT BIOSCIENCES INC | 3,481,042 | $51.9B | 15.58% | |
| 3 | GONGERON CORP | 12,115,926 | $28.4B | 8.50% | |
| 4 | VRDNViridian Therapeutics Inc | 1,164,000 | $23.9B | 7.16% | |
| 5 | SLNSILENCE THERAPEUTICS PLC | 2,104,875 | $21.1B | 6.34% | |
| 6 | CBAYUSDCYMABAY THERAPEUTICS INC | 5,905,400 | $20.7B | 6.20% | |
| 7 | KURAKURA ONCOLOGY INC | 1,348,642 | $18.4B | 5.53% | |
| 8 | ACRSACLARIS THERAPEUTICS INC | 1,144,939 | $18.0B | 5.41% | |
| 9 | AVTEAEROVATE THERAPEUTICS INC | 959,572 | $15.9B | 4.77% | |
| 10 | TRDAENTRADA THERAPEUTICS INC | 642,189 | $10.1B | 3.04% | |
| 11 | ALLKGUSDALLAKOS INC | 1,643,500 | $10.1B | 3.02% | |
| 12 | —AKOUOS INC | 1,350,006 | $9.1B | 2.74% | |
| 13 | TYRATYRA BIOSCIENCES INC | 945,707 | $8.3B | 2.49% | |
| 14 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 1,000,000 | $7.8B | 2.33% | |
| 15 | MRUSMERUS BV | 300,000 | $6.0B | 1.80% | |
| 16 | TNGXTANGO THERAPEUTICS INC | 1,172,250 | $4.2B | 1.27% | |
| 17 | —MAGENTA THERAPEUTICS INC | 2,124,122 | $3.0B | 0.90% | |
| 18 | ZLABZAI LAB LTD-ADR | 72,777 | $2.5B | 0.75% | |
| 19 | MDGLMADRIGAL PHARMACEUTICALS INC | 30,000 | $1.9B | 0.58% | |
| 20 | NVLSEURALPINE IMMUNE SCIENCES INC | 254,569 | $1.8B | 0.55% | |
| 21 | —ELEVATION ONCOLOGY INC | 555,000 | $627.0M | 0.19% |